Search research articles
Contact Us
Filters
Showing results (21-30 of 36) with videos related to
Page
of 4
Sort By:
European Journal of Immunology
|
March 16, 2017
Card9 controls Dectin-1-induced T-cell cytotoxicity and tumor growth in mice
Tobias Haas, Simon Heidegger, Alexander Wintges, et al.
Ebiomedicine
|
March 11, 2019
RIG-I activating immunostimulatory RNA boosts the efficacy of anticancer vaccines and synergizes with immune checkpoint blockade
Simon Heidegger, Diana Kreppel, Michael Bscheider, et al.
Oncoimmunology
|
May 14, 2025
Gasdermin E links tumor cell-intrinsic nucleic acid signaling to proinflammatory cell death for successful checkpoint inhibitor cancer immunotherapy
Stefan Enssle, Anna Sax, Peter May, et al.
The Journal of Pathology
|
July 13, 2022
Experimental investigation of skin toxicity after immune checkpoint inhibition in combination with radiation therapy
Laura Lansink Rotgerink, Hannah Felchle, Annette Feuchtinger, et al.
Journal for Immunotherapy of Cancer
|
May 9, 2025
Defects in the necroptosis machinery are a cancer resistance mechanism to checkpoint inhibitor immunotherapy
Anna Sax, Peter May, Stefan Enssle, et al.
Ebiomedicine
|
October 21, 2023
The microbial metabolite desaminotyrosine enhances T-cell priming and cancer immunotherapy with immune checkpoint inhibitors
Laura Joachim, Sascha Göttert, Anna Sax, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
June 19, 2013
Interleukin-22 is frequently expressed in small- and large-cell lung cancer and promotes growth in chemotherapy-resistant cancer cells
Sebastian Kobold, Stefanie Völk, Till Clauditz, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 27, 2017
A20 Restrains Thymic Regulatory T Cell Development
Julius Clemens Fischer, Vera Otten, Maike Kober, et al.
Nuklearmedizin. Nuclear Medicine
|
January 8, 2024
CXCR4-targeted Theranostics in Hematooncology: Opportunities and Challenges
Rudolf Werner, Alexander Haug, Christian Buske, et al.
Cell Reports
|
October 4, 2023
Negative feedback regulation of MAPK signaling is an important driver of chronic lymphocytic leukemia progression
Veronika Ecker, Lisa Brandmeier, Martina Stumpf, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 36) with videos related to
Sort By:
Page
of 4
European Journal of Immunology
|
March 16, 2017
Card9 controls Dectin-1-induced T-cell cytotoxicity and tumor growth in mice
Tobias Haas, Simon Heidegger, Alexander Wintges, et al.
Ebiomedicine
|
March 11, 2019
RIG-I activating immunostimulatory RNA boosts the efficacy of anticancer vaccines and synergizes with immune checkpoint blockade
Simon Heidegger, Diana Kreppel, Michael Bscheider, et al.
Oncoimmunology
|
May 14, 2025
Gasdermin E links tumor cell-intrinsic nucleic acid signaling to proinflammatory cell death for successful checkpoint inhibitor cancer immunotherapy
Stefan Enssle, Anna Sax, Peter May, et al.
The Journal of Pathology
|
July 13, 2022
Experimental investigation of skin toxicity after immune checkpoint inhibition in combination with radiation therapy
Laura Lansink Rotgerink, Hannah Felchle, Annette Feuchtinger, et al.
Journal for Immunotherapy of Cancer
|
May 9, 2025
Defects in the necroptosis machinery are a cancer resistance mechanism to checkpoint inhibitor immunotherapy
Anna Sax, Peter May, Stefan Enssle, et al.
Ebiomedicine
|
October 21, 2023
The microbial metabolite desaminotyrosine enhances T-cell priming and cancer immunotherapy with immune checkpoint inhibitors
Laura Joachim, Sascha Göttert, Anna Sax, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
June 19, 2013
Interleukin-22 is frequently expressed in small- and large-cell lung cancer and promotes growth in chemotherapy-resistant cancer cells
Sebastian Kobold, Stefanie Völk, Till Clauditz, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 27, 2017
A20 Restrains Thymic Regulatory T Cell Development
Julius Clemens Fischer, Vera Otten, Maike Kober, et al.
Nuklearmedizin. Nuclear Medicine
|
January 8, 2024
CXCR4-targeted Theranostics in Hematooncology: Opportunities and Challenges
Rudolf Werner, Alexander Haug, Christian Buske, et al.
Cell Reports
|
October 4, 2023
Negative feedback regulation of MAPK signaling is an important driver of chronic lymphocytic leukemia progression
Veronika Ecker, Lisa Brandmeier, Martina Stumpf, et al.
Page
of 4